ProCE Banner Activity

Practical Considerations for Administration of Asparaginase-Based Therapy to Patients With ALL: Hypersensitivity or Intolerance or Inactivation?

Slideset Download
Download this slideset from a live CCO symposium for an expert overview of how to identify and optimally manage hypersensitivity reactions associated with asparaginase-based regimens in the treatment of ALL.

Released: June 07, 2022

Expiration: June 06, 2023

No longer available for credit.

Share

Faculty

Kjeld Schmiegelow

Kjeld Schmiegelow, MD, DMSci

Professor
Department of Pediatric Oncology
Righospitalet University Hospital
Copenhagen, Denmark

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by an educational grant from

Jazz Pharmaceuticals Inc

Faculty Disclosure

Primary Author

Kjeld Schmiegelow, MD, DMSci

Professor
Department of Pediatric Oncology
Righospitalet University Hospital
Copenhagen, Denmark

Kjeld Schmiegelow, MD, has disclosed that he has received consulting/advisor/speaker fees from Jazz Pharmaceuticals and Servier.